Viemed Healthcare (NASDAQ:VMD) Director Sells $230,000.00 in Stock

Viemed Healthcare, Inc. (NASDAQ:VMD) Director Timothy Smokoff sold 20,000 shares of the firm’s stock in a transaction on Wednesday, June 24th. The stock was sold at an average price of $11.50, for a total value of $230,000.00. Following the completion of the sale, the director directly owned 75,518 shares of the company’s stock, valued at $868,457. The trade was a 20.94% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Viemed Healthcare Stock Down 0.5%

Shares of VMD stock traded down $0.06 during trading hours on Friday, reaching $11.63. 882,599 shares of the company’s stock were exchanged, compared to its average volume of 260,443. The stock has a market cap of $445.89 million, a PE ratio of 31.43 and a beta of 1.12. Viemed Healthcare, Inc. has a 1 year low of $5.93 and a 1 year high of $11.88. The company has a current ratio of 1.22, a quick ratio of 1.10 and a debt-to-equity ratio of 0.06. The stock’s fifty day moving average price is $9.87 and its two-hundred day moving average price is $8.82.

Viemed Healthcare (NASDAQ:VMD) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.06 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.03). The company had revenue of $75.41 million for the quarter, compared to analyst estimates of $74.40 million. Viemed Healthcare had a net margin of 5.20% and a return on equity of 10.52%. Research analysts predict that Viemed Healthcare, Inc. will post 0.44 EPS for the current year.

Institutional Investors Weigh In On Viemed Healthcare

Several hedge funds and other institutional investors have recently added to or reduced their stakes in VMD. Segall Bryant & Hamill LLC acquired a new stake in shares of Viemed Healthcare during the 3rd quarter worth approximately $1,965,000. Expect Equity LLC raised its position in shares of Viemed Healthcare by 59.6% during the 4th quarter. Expect Equity LLC now owns 173,970 shares of the company’s stock worth $1,293,000 after purchasing an additional 64,961 shares during the last quarter. Cove Street Capital LLC lifted its position in shares of Viemed Healthcare by 57.5% in the third quarter. Cove Street Capital LLC now owns 219,848 shares of the company’s stock valued at $1,493,000 after acquiring an additional 80,227 shares in the last quarter. Ulland Investment Advisors LLC raised its stake in Viemed Healthcare by 142.4% in the 3rd quarter. Ulland Investment Advisors LLC now owns 73,095 shares of the company’s stock valued at $496,000 after purchasing an additional 42,940 shares during the last quarter. Finally, First Eagle Investment Management LLC lifted its stake in shares of Viemed Healthcare by 4.9% in the third quarter. First Eagle Investment Management LLC now owns 477,844 shares of the company’s stock worth $3,245,000 after buying an additional 22,500 shares in the last quarter. 74.24% of the stock is owned by institutional investors and hedge funds.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.